Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Atriva Therapeutics GmbH

http://atriva-therapeutics.com/

Latest From Atriva Therapeutics GmbH

Codagenix-Serum Join Fray To Develop SARS-CoV-2 Vaccine

Codagenix, a company backed by Novartis, Merck and the Bill & Melinda Gates Foundation, has tied up with India’s Serum Institute to develop a vaccine against SARS-CoV-2, joining a heated race against the dreaded COVID-19 outbreak.

Research & Development Vaccines

Atriva Fast Tracks Antiviral Candidate As Coronavirus Arrives In Germany

The antiviral specialist says MEK inhibitor could work against 2019-nCoV, but tests will take time.

International Healthcare Systems

Moderna, Inovio Coronavirus Vaccine Candidates Fast-Tracked By International Coalition

The Coalition for Epidemic Preparedness Innovations adds new deal with mRNA specialist Moderna for rapid development of coronavirus vaccine.

Companies Vaccines

Atriva: Targeting Patients, Not Virus, Is The Way Forward In Flu

Emerging Company Profile: Four-year-old Atriva Therapeutics GmbH is developing a drug to prevent the proliferation of flu virus by transiently inhibiting one of the patient’s own cellular processes, a host-mediated novel mechanism of action that could be effective against a range of respiratory virus infections.

StartUps and SMEs Infectious Diseases
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Atriva Therapeutics GmbH
  • Senior Management
  • Rainer Lichtenberger, CEO
    Sebastian Canisius, MD, PhD, CMO
    Oliver Planz, PhD, CSO
    Henrik Luessen, PhD, CBO
  • Contact Info
  • Atriva Therapeutics GmbH
    Phone: 7071 8597673
    Tübingen,
    Germany
UsernamePublicRestriction

Register